Results 221 to 230 of about 40,395 (311)

Treatment of eruptive keratoacanthoma in the setting of immunosuppression and atopic dermatitis. [PDF]

JAAD Case Rep
Pacyna A, Cahn R, Ghareeb E, Kolodney J, Codrea V.   +4 more
europepmc   +1 more source

Clinically Meaningful Improvements in Quality of Life, Including Sleep, With Two‐Week and Monthly Dosed Rademikibart: A Phase 2 Randomized Trial in Adults With Moderate‐to‐Severe Atopic Dermatitis

JEADV Clinical Practice, EarlyView.
Rademikibart, a potent IL‐4Rα‐targeting antibody, achieved its primary endpoint as a treatment for adults with moderate‐to‐severe atopic dermatitis (AD) in the CBP‐201‐WW001 Phase 2 trial. There is a need for AD treatment options with convenient dosing intervals.
Jonathan I. Silverberg, Emma Guttman‐Yassky, Raúl Collazo   +2 more
wiley   +1 more source

Comparative Evaluation of Spreadability Measurement Methods for Topical Semisolid Formulations/A Scoping Review. [PDF]

Gels
Al-Barghouthy EY, Hamed S, Mehyar GF, AlKhatib HS.   +3 more
europepmc   +1 more source

First Report of Homozygous COL7A1 c.5756delG Mutation Causing Recessive Dystrophic Epidermolysis Bullosa in a Non‐Consanguineous Japanese Family

JEADV Clinical Practice, EarlyView.
ABSTRACT Severe recessive dystrophic epidermolysis bullosa (RDEB) is usually caused by biallelic loss‐of‐function mutations in COL7A1. While the c.5756delG variant has been previously reported in heterozygous form, its clinical impact in homozygosity has not been described.
Nozomi Kohama, Sayaka Yamaguchi, Teruki Yanagi, Yumi Akamine, Kimiko Nonaka, Daisuke Utsumi, Kenzo Takahashi   +6 more
wiley   +1 more source

A Case of Pembrolizumab‐Induced Pityriasis Lichenoides‐Like Eruption Treated Successfully With Dupilumab

JEADV Clinical Practice, EarlyView.
ABSTRACT Immune‐checkpoint inhibitors (ICIs) have revolutionised melanoma treatment but can often cause severe and long‐standing cutaneous immune‐related adverse events (cirAEs). We report a case of refractory pembrolizumab‐induced pityriasis lichenoides (PL)‐like eruption successfully treated with dupilumab, leading to rapid and sustained remission ...
Evangelos Christou, Sharon Edwards, Andrew Affleck   +2 more
wiley   +1 more source

The Therapeutic Potential of West Indian Lemongrass (<i>Cymbopogon citratus</i>) Essential Oil-Based Ointment in the Treatment of Pitted Keratolysis. [PDF]

Antibiotics (Basel)
Schneider G, Schweitzer B, Steinbach AS, Hodován ÁS, Horváth M, Bakó E, Mayer A, Pál S.   +7 more
europepmc   +1 more source

Uncharted

Journal of Hospital Medicine, EarlyView.
Julie Eckelbarger
wiley   +1 more source

Natural Products in Hemorrhoid Management: A Comprehensive Literature Review of Traditional Herbal Remedies and Evidence-Based Therapies. [PDF]

Cureus
Admuthe NB, Karajgi S, Uikey J, Bhimraj NM, Prakash V, Babar TP, Karra T, Shrivastava R.   +7 more
europepmc   +1 more source

Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review

JEADV Clinical Practice, EarlyView.
ABSTRACT In recent years, innovative topical medications with novel mechanisms of action have emerged to treat common dermatologic conditions such as acne, atopic dermatitis, vitiligo, and actinic keratoses. These molecularly targeted therapies offer improved safety and tolerability compared to traditional options like corticosteroids.
Mary Dyson, Kara Hurley, Hannah Chaudhury, Lara Shehadeh, Cameron West   +4 more
wiley   +1 more source